findmyKOL
Clinical trialNCT04439084CompletedObservational

COVID-19 in Patients With Chronic Liver Diseases

SponsorStanford UniversityEnrollment1,025COVID-19Chronic Liver Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Arizona,

    Phoenix, Arizona, United States

  • Mayo Clinic

    Scottsdale, Arizona, United States

  • Ucsf Fresno

    Fresno, California, United States

  • University of Southern California

    Los Angeles, California, United States

  • Stanford University

    Stanford, California, United States

  • Georgetown University

    Washington D.C., District of Columbia, United States

  • Va Medical Center

    Washington D.C., District of Columbia, United States

  • University of Miami

    Miami, Florida, United States

  • Rush University Medical Center

    Chicago, Illinois, United States

  • the University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Oschner Medical Center

    Baton Rouge, Louisiana, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Hennepin County Medical Center (hcmc)

    Minneapolis, Minnesota, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Mount Sinai School of Medicine

    New York, New York, United States

  • Weill Cornell Medicine

    New York, New York, United States

  • Duke University

    Durham, North Carolina, United States

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Mar 2020
Primary completion
31 Jul 2021
Completion
31 Jul 2021
Last update posted
9 Aug 2021
Registered enrollment
1,025
Registry id
NCT04439084

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.